[Sponsored] A new eBook explores how using real world data from patients can help drug developers improve outcomes for non-small cell lung cancer and other patient populations.

The post How to Use Real-World Data to Improve Drug Development, Starting with the Patient Journey appeared first on MedCity News.

[Sponsored] A new eBook, sponsored by PurpleLab, examines how a significant number of patients with non-small cell lung cancer miss out on optimal care due to gaps in biomarker testing, socioeconomic barriers, incomplete patient journey data, and what can be done to change that.

The post How Real-World Data Is Reshaping the NSCLC Patient Journey appeared first on MedCity News.

[Sponsored] A new eBook published by MedCity News for PurpleLab highlights how RWD and SDOH can lead to more inclusive clinical trials and drugs that improve the quality of life for larger, diverse patient populations not only for NSCLC, but other conditions as well.

The post Using Real World Data from the Patient Experience to Improve Drug Development appeared first on MedCity News.

[Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people.

The post The Role of RWD in Revolutionizing Clinical Trial Design appeared first on MedCity News.

[Sponsored] For non small cell lung cancer patients, a zip code can mean the difference between diagnosis time and treatment options.

The post SDOH in Oncology: Mapping Out How Zip Code Can Affect Care Is a Critical Step to Improving Outcomes appeared first on MedCity News.

[Sponsored] This article is part of a series on eliminating blind spots in the patient journey by leveraging real-world data.

The post Using RWD, SDoH and Patient Mapping to Eliminate Blind Spots from the Patient Journey appeared first on MedCity News.

[Sponsored] A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access.

The post How Can RWD Transform the Patient Journey? appeared first on MedCity News.

[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer.

The post Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies appeared first on MedCity News.

[Sponsored] PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies.

The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.